Clinical trial
Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients
NCT02654145
Study timeline
Study start (actual)2016-03-17Date precision: day
Registry last updated2019-08-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Interventions
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
TorontoOntario, Canada2BerlinGermany2BaltimoreMaryland, United States1BarcelonaSpain1ParisFrance1BirminghamAlabama, United States1San DiegoCalifornia, United States1MontrealQuebec, Canada1DurhamNorth Carolina, United States1RochesterNew York, United States1CharlotteNorth Carolina, United States1RichmondVirginia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02654145 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.